Bifiform caps. kish.rastv. 30 pc

Description

Composition
Active substance:
1 capsule contains: active substance: Enterococcus faecium 1 x 10 million CFU
Bifidobacterium longum 1 x 10 million CFU.
Excipients:
Dextrose 154.1 mg, Sourdough yeast 17.5 mg Carob bean gum 12.5 mg Magnesium stearate 3.0 mg 0.5 mg Lactulose.
The composition of the capsule shell:
Gelatin 50.0 mg Titanium dioxide (1.0 mg), * Methacrylic acid-methyl methacrylate copolymer [1: 1] 2.2 mg of methacrylic acid ethyl acrylate copolymer [1: 1] [30% dispersion] 7.7 mg , Talc 5.6 mg Macrogol 6000 1.5 mg Soy bean oil 0.8 mg, 0.3 mg of diacetylated glycerides. * Weight of titanium dioxide included in the total weight of the gelatin capsule.
Description:
Hard gelatine capsules No. 3 white. Contents of capsules – powder light yellow with a gray tint.
Product form:
Enteric capsule. 20, 30, or 40 capsules per box were aluminum, polyethylene-closed stopper to control the first opening comprising a desiccant. 1 canisters with instructions for use placed in a cardboard box.
Contraindications
Individual hypersensitivity to the drug.
Indications
– diarrhea, caused by acute exacerbation of chronic gastroenteritis, rotavirus; antibiotic-associated diarrhea; traveler’s diarrhea; – in the treatment of acute intestinal infections; – in the treatment of chronic diseases of the gastrointestinal tract, such as colitis, irritable bowel syndrome and other gastrointestinal disorders functional genesis; – normalization of intestinal microflora, treatment and prevention of dysbacteriosis and maintenance of the immune system in children older than 2 years and adults; – lactose intolerance; – as part of a comprehensive standard eradication therapy in patients with H. pylori infection.
Interaction with other drugs
The preparation may be used in combination with other drugs.
Permission is granted to co-administration with antibiotics.
Overdose
Symptoms of overdose have not previously registered. In case of a significant excess of the recommended doses is expedient medical supervision.
pharmachologic effect
Pharmacological group:
Eubiotics.
Pharmacological properties:
Strains of Enterococcus faecium and Bifidobacterium longum, are part of the drug, are natural symbiotic bacteria inhabiting the gastrointestinal tract.
The drug has a normalizing effect on the quantitative and qualitative composition of intestinal microflora. Action due to both a direct direct effect included in the preparation components (high antagonistic activity against pathogenic and conditionally pathogenic microorganisms) and indirectly – stimulation of the local intestinal immunity (immunoglobulin A synthesis activation, induction of endogenic interferon synthesis).
Bifidobacterium longum has a high survival in the human intestine and high growth rate. Inclusion in drug nonpathogenic Enterococcus Enterococcus faecium, colonizing normal small intestine, allows to have a positive impact on the state and the digestive function is not only fat, but also of the small intestine, especially in the presence of fermentation dyspepsia and flatulence phenomena.
Pregnancy and breast-feeding
Application Bifiform drug during pregnancy and lactation is considered safe because the drug is not absorbed and has no systemic action.
Conditions of supply of pharmacies
Without recipe.
side effects
When used in the recommended doses at established indications side effects are not revealed.
special instructions
The drug does not affect the ability to drive a car, and management mechanisms.
Precautions: Do not exceed the maximum daily dose.
Storage conditions
In a dry place at a temperature not higher than 25 ° C.
Keep out of the reach of children.
Dosing and Administration
In acute diarrhea, the drug should be taken 1 capsule 4 times a day until the normalization of stool. Then the drug must be continued at a dose of 2-3 capsules per day until complete disappearance of symptoms.
To normalize intestinal microflora and immune system support the drug is prescribed in a dose of 2-3 capsules per day 10-21 days.
Patients with lactose intolerance to take medication 1 capsule three times a day. During the eradication therapy prescribed Bifiform 2 capsules 2 times a day for two weeks from the first day eradication therapy.
Children from 2 years to 1 capsule 2-3 times a day. If the child can not swallow a capsule, it is necessary to open and mix the contents with a small amount of liquid.
Information
Appearance may differ from that depicted in the picture. There are contraindications. You need to read the manual or consult with a specialist